Evidence map›Paper›PMID 36672676›Full record

ArticleBiomedicines2023

Multi-Mechanistic and Therapeutic Exploration of Nephroprotective Effect of Traditional Ayurvedic Polyherbal Formulation Using In Silico, In Vitro and In Vivo Approaches.

Gaurav, Ikshit Sharma, Mohammad Umar Khan, Sultan Zahiruddin, Parakh Basist, Sayeed Ahmad

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Yellow Himalayan Raspberry (Molecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

GauravCentre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0002-0530-0788
Ikshit SharmaAIMIL Pharmaceuticals (India) Ltd., Saini Majra, Ropar Nalagarh Road, Solan District, Nalagarh 174101, India.
Mohammad Umar KhanCentre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India.
Sultan ZahiruddinCentre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India.
Parakh BasistCentre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India.
Sayeed AhmadCentre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0003-1573-152X
Jamia Hamdard · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on traditional therapeutic claims, NEERI KFT (a traditional Ayurvedic polyherbal preparation) has been innovatively developed in recent time on the decades of experience for treating kidney dysfunction. Due to the lack of scientific evidence, the present investigations are needed to support the rationale use of NEERI KFT. Considering the facts, the study investigated the nephroprotective effect of NEERI KFT against kidney dysfunction using in silico, in vitro and in vivo approaches. In this study, phytochemical and network pharmacology studies were performed for the developed formulation to evaluate the molecular mechanism of NEERI KFT in the amelioration of kidney disease. In vitro nephroprotective and antioxidant effect of NEERI KFT was determined on HEK 293 cells against cisplatin-induced cytotoxicity and oxidative stress. In vivo nephroprotective effect of NEERI KFT was determined against cisplatin-induced nephrotoxicity in Wistar rats, via assessing biochemical markers, antioxidant enzymes and inflammatory cytokines such as TNF-α, IL-1β, CASP-3, etc. The results showed that the compounds such as gallic acid, caffeic acid and ferulic acid are the major constituents of NEERI KFT, while network pharmacology analysis indicated a strong interaction between polyphenols and several genes (CASPs, ILs, AGTR1, AKT, ACE2, SOD1, etc.) involved in the pathophysiology of kidney disease. In vivo studies showed a significant (p < 0.05) ameliorative effect on biochemical markers and antioxidant enzymes (SOD, CAT, GSH, etc.), and regulates inflammatory cytokine (TNF-α, IL-1β, CASP-3) expression in kidney tissue. Hence, it can be concluded that NEERI KFT subsequently alleviates renal dysfunction mediated by cisplatin via attenuating oxidative and inflammatory stress, thus preserving the normalcy of kidney function.

Indexed as

anti-inflammatory activityantioxidant activitycisplatinNEERI KFTnephrotoxicitynetwork pharmacology

Identifiers

PMID36672676
PMCPMC9855918
OpenAlexW4313888903

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.